Search

everythinglearnresearchcommunity

for

Search:↓

IGF-1R may play a role in female hair loss and could be a treatment target.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

Trichoscopy is better than trichogram for diagnosing early female hair loss.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Finasteride may effectively treat female pattern hair loss.

Hair thickness differences help diagnose hair loss severity.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

New treatments for common hair loss are needed.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

PRP helps skin regeneration but needs standardized testing for consistent results.

SKPs are similar to adult skin stem cells and could help in skin repair and hair growth.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Longer CAG repeats in gene linked to more severe hair loss in females.

Dermoscopy is useful for diagnosing different types of hair loss.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.